Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triple Intralesional Antigen Immunotherapy Versus Monoantigen in the Treatment of Multiple Recalcitrant Warts

NCT05254561 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT05254561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05254561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triple Intralesional Antigen Immunotherapy Versus Monoantigen in the Treatment of Multiple Recalcitrant Warts
Lead sponsor
Zagazig University
Phase
Phase 2/3
Overall status
Completed
Start date
November 20, 2020
Completion date
November 15, 2021
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

triple intralesional immunotherapy combination in multiple recalcitrant warts